-5%
Flupenthixol + Melitracen treats-
- Anxiety, depression, and asthenia (weakness) also include neurasthenia, psychogenic depression, masked depression, menopausal depression, dysphoria, and depression in alcoholics and drug addicts
- Psychosomatic affections accompanied by anxiety and apathy with depressive neuroses
Renxit 10mg Tablet contains Flupenthixol and Melitracen, which are classified as antipsychotics and tricyclic antidepressants, respectively. It is prescribed to treat various conditions such as anxiety, depression, and asthenia (lack of energy or strength). Additionally, it is used to manage neurasthenia, psychogenic depression, masked depression, menopausal depression, dysphoria, depression in alcoholics and drug addicts, and psychosomatic conditions associated with anxiety and apathy with depressive neuroses.
Anxiety is characterized by feelings of fear, dread, and uneasiness, often accompanied by physical symptoms like increased heart rate, rapid breathing, sweating, and fatigue. Depression, on the other hand, is a mood disorder that leads to persistent sadness and loss of interest in activities, causing emotional and physical problems. Symptoms of depression include changes in sleep patterns, appetite, and daily behaviors.
However, Renxit 10mg Tablet should be avoided by manic patients and individuals with certain heart conditions like circulatory collapse or a depressed level of consciousness, as well as those with blood disorders or hereditary galactose intolerance.
Before starting Renxit 10mg Tablet, it is essential to inform your doctor if you have a history of convulsions, organic brain syndrome, past suicide-related events, diabetes, planned surgeries, or reduced liver or kidney function.
Pregnant women are generally not advised to use Renxit 10mg Tablet unless recommended by their doctor. For breastfeeding women, caution should be exercised as the medication can pass through breast milk.
